Updated Safety Warnings for Finasteride and Dutasteride The MHRA has completed a review of finasteride and dutasteride, two commonly prescribed medications for benign prostatic hyperplasia and male-pattern hair loss, and has identified important new safety information regarding psychiatric side effects and sexual dysfunction. Key Points The MHRA has reviewed evidence linking finasteride and dutasteride to […]